BAYRY News and Press, Bayer AG ADR From 06/10/22

Bayer (OTCPK:BAYRY) said on Friday that a Missouri court ruled in its favor in a trial regarding claims that its Roundup weedkiller causes cancer, which would mark a third consecutive court victory for the company in the U.S. Previously, three U.S. juries had found in favor of plaintiffs who ...

Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) Cambridge, Mass.-based subsidiary BlueRock Therapeutics has set up a new site for cell therapy innovation at Bayer's campus in Berlin. The German conglomerate said BlueRock will benefit from the expertise of teams at Bayer to accelerate BlueRock's clinical ...

Moovly Media (OTCPK:MVVYF) has signed a Global Partnership Agreement with Bayer AG (OTCPK:BAYRY). Bayer's areas of business include pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds, and biotechnology products. Per the terms, Bayer to deploy and use Moovly's platfor...

Illumina (NASDAQ:ILMN) said it added a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight Oncology (TSO) comprehensive (EU) test. The company said the CDx pan-cancer indication enables targeted therapy with Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) Vi...

Atara Biotherapeutics (NASDAQ:ATRA), a biotech focused on immunotherapies, continues to trade lower on Monday after announcing that German conglomerate Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) decided to end a licensing deal with the company for two of its CAR T-cell therapies. In reaction, H.C...

The following slide deck was published by Bayer Aktiengesellschaft in conjunction with this event. For further details see: Bayer Aktiengesellschaft (BAYRY) Presents At BMO Global Farm to Market Conference

Atara Biotherapeutics (NASDAQ:ATRA) on Thursday said its collaboration partner Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) had decided to end the exclusive worldwide licensing agreement between the companies to develop CAR T-cell therapies. ATRA stock slides 15.4% to $4.34 in aftermarket trad...

China's National Medical Products Administration approved Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) and Merck's (MRK) Verquvo to treat to treat certain patients with heart failure (HF). Verquvo (vericiguat ) can now be used in China to reduce the risk of HF hospitalization or requ...

Lannett (NYSE:LCI) signed an agreement with Areva Pharmaceuticals to be the exclusive U.S. distributor of Fludarabine Phosphate for injection, a generic version of Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) Fludara to treat  chronic lymphocytic leukemia. Trevose, Pa.-based L...

The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2022 Q1 earnings call. For further details see: Bayer Aktiengesellschaft 2022 Q1 - Results - Earnings Call Presentation